Analytical Biosciences - About the company
Analytical Biosciences is a series A company based in San Francisco (United States), founded in 2018 by Zemin Zhang. It operates as a Developer of precision medicine in cancer using single-cell genomics and bioinformatics platform. Analytical Biosciences has raised an undisclosed amount in funding from investors like SBCVC, Sequoia Capital China and IDG Capital. The company has 397 active competitors, including 134 funded and 86 that have exited. Its top competitors include companies like MedGenome, Geneoscopy and Intellia Therapeutics.
Company Details
Developer of precision medicine in cancer using single-cell genomics and bioinformatics platform. The company uses its proprietary bioinformatics tools to identify rare cell types, perform cell lineage tracking, infer developmental trajectories, spatial distributions and inter-cellular interactions of single cells. It includes single-cell 3’/5’ RNA sequencing, single-cell immune profiling, single-cell full-length RNA sequencing, and single-cell chromatin accessibility profiling. The company's platform can also be used for the discovery of drug targets and biomarkers.
- Website
- www.abiosciences.com/
- Social
- Email ID
- *****@abiosciences.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2018
Location
San Francisco, United States
Stage
Series A
Latest Funding Round
Ranked
164th among 397 active competitors
Employee Count
19 as on Mar 31, 2026
Sign up to download Analytical Biosciences' company profile
Analytical Biosciences's funding and investors
Analytical Biosciences has raised funding over 3 rounds. Its first funding round was on 2019. Its latest funding round was a Series A round on May 25, 2021 for $*****. 3 investors participated in its latest round. Analytical Biosciences has 5 institutional investors.
Here is the list of recent funding rounds of Analytical Biosciences:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 25, 2021 | 3075335 | Series A | 4036761 | 8782831 | 1977674 | 7929712 |
Dec 29, 2020 | 5131892 | Series A | 8900169 | 6122879 | 1956559 | |
2019 | 5260 | Series A | 5941 | 6003 | 3212 |
Access funding benchmarks and valuations. Sign up today!View details of Analytical Biosciences's funding rounds and investors
Analytical Biosciences' founders and board of directors
Founder? Claim ProfileThe founders of Analytical Biosciences is Zemin Zhang. Yangzhou Wang is the CEO of Analytical Biosciences.
Here are the details of Analytical Biosciences' key team members:
- Zemin Zhang: Founder of Analytical Biosciences.
- Yangzhou Wang: CEO of Analytical Biosciences. Contact Info: 1 email address
View details of Analytical Biosciences's Founder profiles and Board Members
Analytical Biosciences' employee count trend
Analytical Biosciences has 19 employees as of Mar 26. Here is Analytical Biosciences's employee count trend over the years:
Uncover Analytical Biosciences' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Analytical Biosciences's Competitors and alternates
Top competitors of Analytical Biosciences include MedGenome, Geneoscopy and Intellia Therapeutics. Here is the list of Top 10 competitors of Analytical Biosciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of DNA sequencing, bioinformatics, and multiomics services | $264M | 71/100 | ||
2nd | Geneoscopy 2015, St. Louis (United States), Series C | Developer of non-invasive biomarker tests for colorectal cancer | $219M | 67/100 | |
3rd | Intellia Therapeutics 2014, Cambridge (United States), Public | Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases | $85M | 66/100 | |
4th | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 66/100 | |
5th |  UniQure 1998, Amsterdam (Netherlands), Public | Developer of gene-based therapies for patients with genetic or acquired diseases | $111M | 62/100 | |
6th |  Deep Genomics 2014, Toronto (Canada), Series C | AI-powered platform for RNA biology to accelerate genetic therapy discovery | $238M | 62/100 | |
7th | Personalis 2011, Menlo Park (United States), Public | Provider of genomic sequencing and diagnosis software for the healthcare industry | $87.3M | 61/100 | |
8th | Exicure 2009, Skokie (United States), Public | developer of gene silencing & immunomodulatory drugs using spherical nucleic acid (SNA) technology | $72.3M | 61/100 | |
9th | GenSight Biologics 2011, Paris (France), Public | Developer of viral vector-based gene therapies for retinal neurodegenerative diseases | $76.6M | 61/100 | |
10th |  Seres Therapeutics 2010, Cambridge (United States), Public | Developer of microbiome therapeutics to treat a wide range of diseases | $134M | 60/100 | |
164th |  Analytical Biosciences 2018, San Francisco (United States), Series A | Developer of precision medicine in cancer using single-cell genomics and bioinformatics platform | - | 35/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Analytical Biosciences's competitors? Click here to see the top ones
Analytical Biosciences's Investments and acquisitions
Analytical Biosciences has made no investments or acquisitions yet.
Reports related to Analytical Biosciences
Here is the latest report on Analytical Biosciences's sector:
News related to Analytical Biosciences
•
•
•
•
•
Baiao Zhihui completed a new round of financingPEdaily•Dec 28, 2020•Analytical Biosciences, SBCVC, IDG Capital, Apricot Capital
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Analytical Biosciences
Explore our recently published companies
- Capitalsfb.com - 2018 founded, Unfunded company
- Specule - Delhi based, 2017 founded, Unfunded company
- Tech Hive Technologies - Rawalpindi based, 2017 founded, Unfunded company
- Wise Accelerate - Hanoi based, 2021 founded, Unfunded company
- AblyCon Global - Bengaluru based, 2014 founded, Unfunded company
- Civoya - 2025 founded, Unfunded company
